Iscalimab 600 mg: justified or excessive? - Authors' reply
Fisher, Benjamin A Mariette, Xavier Hueber, Wolfgang
Fisher, Benjamin A
Mariette, Xavier
Hueber, Wolfgang
Affiliation
University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Assistance Publique-Hôpitaux de Paris; Université Paris-Saclay; Novartis Pharma
Other Contributors
Publication date
2025-05-03
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Fisher BA, Mariette X, Hueber W. Iscalimab 600 mg: justified or excessive? - Authors' reply. Lancet. 2025 May 3;405(10489):1578-1579. doi: 10.1016/S0140-6736(25)00357-5.
Type
Correspondence